Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2003
09/03/2003EP1339739A2 Methods and compositions involved in groucho-mediated differentiation
09/03/2003EP1339738A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
09/03/2003EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus
09/03/2003EP1339427A2 Method of producing biospecific molecules by protein trans-splicing
09/03/2003EP1339356A2 Tissue-engineered vascular structures
09/03/2003EP1339349A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
09/03/2003EP1244732B1 Carrier beads for cell culture bearing particular properties and production thereof
09/03/2003EP0914614B1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc
09/03/2003EP0857210B1 Therapeutic antiangiogenic compositions and methods
09/03/2003EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
09/03/2003EP0763116B1 Recombinant viruses, preparation and use thereof in gene therapy
09/03/2003EP0751780B1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods
09/03/2003EP0711349B1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
09/03/2003EP0607297B1 Hormone analogs with multiple ctp extensions
09/03/2003CN1440462A Method of identifying and producing antigen peptides and use thereof as vaccines
09/03/2003CN1440459A Expression system
09/03/2003CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
09/03/2003CN1440423A Immunoadhesin for the prevention of rhinovirus infection
09/03/2003CN1440299A Method for producing bio-artificial transplant
09/03/2003CN1440297A photodynamic treatment and UV-B irradiation of thrombocyte suspension
09/03/2003CN1439717A Method for separating and in vitro culturing stem cells
09/03/2003CN1120240C Plant virus resistance conferring polyribozyme and resistant plants producing same
09/02/2003US6613962 Given DNA sequence; insect resistance
09/02/2003US6613881 Isolated polypeptide of given amino acid sequence; can use in vaccines
09/02/2003US6613751 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
09/02/2003US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents
09/02/2003US6613569 Inducible packaging cell lines for lentivirus vectors
09/02/2003US6613568 Exposing a human embryonic stem cell culture to mammalian hematopoietic stromal cells so as to thereby create human hematopoietic cells which are CD34+
09/02/2003US6613566 Platelet suspensions and methods for resuspending platelets
09/02/2003US6613565 Use of delta-like protein to inhibit the differentiation of stem cells
09/02/2003US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine
09/02/2003US6613544 Osteoprotegerin
09/02/2003US6613538 Detection of HLA-G
09/02/2003US6613531 Detecting modulators of enzymes associated with transcriptional activities; obtain cells, incubate with modulators, monitor adjustment in enzyme activities
09/02/2003US6613521 Nucleic acids; CARD (Caspase Recruitment Domain) proteins; primers; hybridization probes; use in diagnosis, therapy for disorders from with abnormal levels of apoptotic cell death or abnormal activity of FAS/APO-1 or TNF receptor complexes
09/02/2003US6613331 Vaccine against Lyme disease
09/02/2003US6613328 Methods of treating thrombotic diseases with von Willebrand factor specific antibodies
09/02/2003US6613320 Recombinant CD4+ T cells from an individual afflicted with hyper IgM syndrome transformed with vectors carrying either the wild type or the mutagenized CD40Ls, metabolically radiolabeled, and examined for expression
08/2003
08/28/2003WO2003070981A2 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
08/28/2003WO2003070974A2 Mismatch repair detection
08/28/2003WO2003070965A2 The eaat2 promoter and uses thereof
08/28/2003WO2003070937A1 Protein having osteogenic protein-binding region and gene encoding the same
08/28/2003WO2003070933A2 Process of cell electrofusion
08/28/2003WO2003070929A1 Regulation of human zinc protease signature-containing protein
08/28/2003WO2003070922A1 Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
08/28/2003WO2003070921A1 METHODS FOR PRODUCING Ϝδ T CELLS
08/28/2003WO2003070920A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof
08/28/2003WO2003070908A2 Novel spinosyn-producing polyketide synthases
08/28/2003WO2003070907A2 Novel fungal lipase
08/28/2003WO2003070901A2 Heat stable mutants of starch biosynthesis enzymes
08/28/2003WO2003070889A2 Prostate specific genes and the use thereof in design or therapeutics
08/28/2003WO2003070883A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
08/28/2003WO2003070875A2 Container with at least one electrode
08/28/2003WO2003070771A1 Rrp sequences and knockout mice and uses thereof
08/28/2003WO2003070765A2 Growth hormone fusion protein
08/28/2003WO2003070760A2 Anti-amyloid beta antibodies and their use
08/28/2003WO2003070752A2 Mhc-peptide complex binding ligands
08/28/2003WO2003070747A2 Insulin and igf-1 receptor agonists and antagonists
08/28/2003WO2003070197A2 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070171A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003WO2003070084A2 Artificial vessel scaffold and artificial organs therefrom
08/28/2003WO2003070083A2 Endothelial precursor cells for enhancing and restoring vascular function
08/28/2003WO2003069972A2 Hepatocyte precursor cell lines
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003043986A8 Polypeptides of moraxella (branhamella) catarrhalis
08/28/2003WO2003034037A3 Apparatus and method for destacking articles
08/28/2003WO2003029289A3 Fragements of heat shock proteins and their use
08/28/2003WO2003025183A3 Random integration of a polynucleotide after in vivo linearization
08/28/2003WO2003025018A3 Dimeric and multimeric antigen binding structure
08/28/2003WO2003025015A3 A soluble toll-like receptor
08/28/2003WO2003020894A3 Insulin related transcription factor and uses thereof
08/28/2003WO2003020757A3 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
08/28/2003WO2003018631A3 Nogo receptor homologues and their use
08/28/2003WO2003016867A3 Method and quantification assay for determining c-kit/scf/pakt status
08/28/2003WO2003016522A3 Methods and compounds for the targeting of protein to exosomes
08/28/2003WO2003012080A3 Ex-vivo selection of t-cells with reduced alloreactivity and use thereof in bone marrow transplantations
08/28/2003WO2003007879A3 Cartilage repair and regeneration scaffold and method
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002102837A3 Marker for identifying hematopoietic stem cells
08/28/2003WO2002099383A3 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002088328A3 Method for generating highly active human dendritic cells from monocytes
08/28/2003WO2002086112A3 Nucleic acid molecules encoding starch degrading enzymes
08/28/2003WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
08/28/2003WO2002083188A9 Dense/porous structures for use as bone substitutes
08/28/2003WO2002081628A8 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
08/28/2003WO2002074048A8 P-glycoproteins and uses thereof
08/28/2003WO2002070006A3 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
08/28/2003WO2002054073A3 Latent human tuberculosis model, diagnostic antigens, and methods of use
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002043478A3 Transgenic transchromosomal rodents for making human antibodies
08/28/2003WO2002036627A3 Interferons, uses and compositions related thereto
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
08/28/2003WO2002034922A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
08/28/2003WO2002018948A3 Differentially expressed epitopes and uses thereof
08/28/2003WO2002012470A3 A member of the lysyl oxidase gene family
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2002008399A3 Human kinases
08/28/2003WO2002007752A3 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
08/28/2003WO2002002780A3 Human serine-threonine kinase
1 ... 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 ... 1827